These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25016798)

  • 21. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.
    Wang H; Sica RA; Kaur G; Galbo PM; Jing Z; Nishimura CD; Ren X; Tanwar A; Etemad-Gilbertson B; Will B; Zheng D; Fooksman D; Zang X
    Nat Commun; 2024 Jan; 15(1):11. PubMed ID: 38167704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Almohsen F; Al-Mudallal SS
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ara-C and anti-CD47 antibody combination therapy eliminates acute monocytic leukemia THP-1 cells in vivo and in vitro.
    Wang Y; Yin C; Feng L; Wang C; Sheng G
    Genet Mol Res; 2015 May; 14(2):5630-41. PubMed ID: 26125761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting myeloid leukemia stem cells.
    Jordan CT
    Sci Transl Med; 2010 May; 2(31):31ps21. PubMed ID: 20463365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.
    Schneider V; Zhang L; Rojewski M; Fekete N; Schrezenmeier H; Erle A; Bullinger L; Hofmann S; Götz M; Döhner K; Ihme S; Döhner H; Buske C; Feuring-Buske M; Greiner J
    Int J Cancer; 2015 Nov; 137(9):2083-92. PubMed ID: 25912930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting acute myeloid leukemia stem cell signaling by natural products.
    Siveen KS; Uddin S; Mohammad RM
    Mol Cancer; 2017 Jan; 16(1):13. PubMed ID: 28137265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
    Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
    Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells.
    Li H; Zhao N; Li Y; Xing H; Chen S; Xu Y; Tang K; Tian Z; Wang M; Rao Q; Wang J
    Stem Cells; 2018 Nov; 36(11):1685-1696. PubMed ID: 30106501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.
    Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C
    Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.
    Hope KJ; Jin L; Dick JE
    Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways.
    Kikushige Y
    Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.
    Qi J; Singh S; Hua WK; Cai Q; Chao SW; Li L; Liu H; Ho Y; McDonald T; Lin A; Marcucci G; Bhatia R; Huang WJ; Chang CI; Kuo YH
    Cell Stem Cell; 2015 Nov; 17(5):597-610. PubMed ID: 26387755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.
    Saito Y; Yuki H; Kuratani M; Hashizume Y; Takagi S; Honma T; Tanaka A; Shirouzu M; Mikuni J; Handa N; Ogahara I; Sone A; Najima Y; Tomabechi Y; Wakiyama M; Uchida N; Tomizawa-Murasawa M; Kaneko A; Tanaka S; Suzuki N; Kajita H; Aoki Y; Ohara O; Shultz LD; Fukami T; Goto T; Taniguchi S; Yokoyama S; Ishikawa F
    Sci Transl Med; 2013 Apr; 5(181):181ra52. PubMed ID: 23596204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myeloid leukemia: therapeutic targeting of stem cells.
    Pabon CM; Abbas HA; Konopleva M
    Expert Opin Ther Targets; 2022 Jun; 26(6):547-556. PubMed ID: 35634856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of acute myeloid leukemia stem cells.
    Pollyea DA; Jordan CT
    Blood; 2017 Mar; 129(12):1627-1635. PubMed ID: 28159738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
    Kikushige Y; Miyamoto T; Akashi K
    Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia.
    Laverdière I; Boileau M; Neumann AL; Frison H; Mitchell A; Ng SWK; Wang JCY; Minden MD; Eppert K
    Blood Cancer J; 2018 Jun; 8(6):52. PubMed ID: 29921955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.
    Dorrance AM; Neviani P; Ferenchak GJ; Huang X; Nicolet D; Maharry KS; Ozer HG; Hoellarbauer P; Khalife J; Hill EB; Yadav M; Bolon BN; Lee RJ; Lee LJ; Croce CM; Garzon R; Caligiuri MA; Bloomfield CD; Marcucci G
    Leukemia; 2015 Nov; 29(11):2143-53. PubMed ID: 26055302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.